Edition:
United States

Search Results  for '600664.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Harbin Pharmaceutical Group Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Harbin Pharmaceutical Group Co Ltd (600664-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Harbin Pharmaceutical Group Company Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

31 Oct 2016 Wright Reports 69 $75.00

Harbin Pharmaceutical Group Co., Ltd.: Upgraded to Below Average

11 Oct 2016 Sadif Analytics Prime 3 $10.00

Will Harbin Pharmaceutical Group Co., Ltd. Deliver Top-Shelf Performance?

13 Sep 2016 Sadif Analytics Prime 12 $25.00

Harbin Pharmaceutical Group Co., Ltd.: Downgraded to Risky

12 Jul 2016 Sadif Analytics Prime 3 $10.00

Is Harbin Pharmaceutical Group Co., Ltd. Worth a Higher Bid?

14 Jun 2016 Sadif Analytics Prime 12 $25.00

Harbin Pharmaceutical Group Co., Ltd.: Upgraded to Below Average

12 May 2016 Sadif Analytics Prime 3 $10.00

Thomson Reuters Stock Report - Harbin Pharmaceutical Group Co Ltd (600664-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Will Harbin Pharmaceutical Group Co., Ltd. Deliver Top-Shelf Performance?

15 Mar 2016 Sadif Analytics Prime 12 $25.00